16,100 Shares in HCA Healthcare, Inc. (NYSE:HCA) Acquired by Genus Capital Management Inc.

Genus Capital Management Inc. bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 16,100 shares of the company's stock, valued at approximately $5,563,000.

Other hedge funds have also added to or reduced their stakes in the company. MJP Associates Inc. ADV bought a new stake in HCA Healthcare in the 1st quarter worth approximately $222,000. Cerity Partners LLC lifted its position in HCA Healthcare by 9.7% in the first quarter. Cerity Partners LLC now owns 30,844 shares of the company's stock valued at $10,658,000 after purchasing an additional 2,718 shares during the last quarter. Alps Advisors Inc. lifted its position in HCA Healthcare by 44.9% in the first quarter. Alps Advisors Inc. now owns 1,332 shares of the company's stock valued at $460,000 after purchasing an additional 413 shares during the last quarter. Allworth Financial LP lifted its position in HCA Healthcare by 8.7% in the first quarter. Allworth Financial LP now owns 798 shares of the company's stock valued at $272,000 after purchasing an additional 64 shares during the last quarter. Finally, Capital Insight Partners LLC lifted its position in HCA Healthcare by 6.0% in the first quarter. Capital Insight Partners LLC now owns 3,878 shares of the company's stock valued at $1,340,000 after purchasing an additional 220 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

Insider Activity at HCA Healthcare

In other news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the transaction, the chief operating officer owned 12,646 shares in the company, valued at approximately $4,670,420.72. The trade was a 55.38% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.30% of the company's stock.

HCA Healthcare Stock Performance

HCA traded down $2.56 during midday trading on Friday, reaching $375.76. The company had a trading volume of 877,097 shares, compared to its average volume of 1,459,427. The company has a quick ratio of 1.06, a current ratio of 1.19 and a debt-to-equity ratio of 69.07. The business has a 50-day moving average of $374.58 and a two-hundred day moving average of $341.23. The company has a market cap of $90.40 billion, a P/E ratio of 16.71, a P/E/G ratio of 1.31 and a beta of 1.47. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.75 by $0.70. The firm had revenue of $18.32 billion during the quarter, compared to analysts' expectations of $18.26 billion. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The firm's revenue was up 5.7% on a year-over-year basis. During the same quarter last year, the business posted $5.36 earnings per share. As a group, equities research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, June 30th. Stockholders of record on Monday, June 16th were issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.77%. The ex-dividend date was Monday, June 16th. HCA Healthcare's dividend payout ratio (DPR) is 12.81%.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. Barclays set a $416.00 target price on HCA Healthcare and gave the company an "overweight" rating in a research note on Monday, June 2nd. Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th. Wells Fargo & Company raised HCA Healthcare from an "underweight" rating to an "equal weight" rating and upped their price target for the stock from $320.00 to $385.00 in a research note on Thursday, May 29th. Stephens raised HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Finally, Baird R W cut HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Seven equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, HCA Healthcare presently has an average rating of "Moderate Buy" and an average target price of $395.71.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.